55.19 USD
↗ 0.70 (1.28%)PRE MARKET (AS OF 08:03 AM EDT)
Moderna, Inc. Common Stock
MRNANASDAQ • USD
Market: OPEN
Moderna, Inc. Common Stock (MRNA) is currently trading at $55.19. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. MRNA is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jul 29, 2026.
Open?$54.81
High?$55.29
Low?$54.54
Prev. Close?$54.49
Volume?34.8K
Avg. Volume?8.4M
VWAP?$54.99
Rel. Volume?0.00x
Bid / Ask
Bid?$52.25 × 100
Ask?$57.27 × 100
Spread?$5.02
Midpoint?$54.76
Valuation & Ratios
Market Cap?21.6B
Shares Out?396.8M
Float?361.1M
Float %?91.0%
P/E Ratio?N/A
P/B Ratio?2.92
EPS?-$8.05
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Themes
Employees
4.7K
Market Cap
22.1B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2018-12-07
Address
325 BINNEY STREET
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?83
Momentum?35
Short Sent.?54
Piotroski F-Score?1/9Weak
Altman Z-Score?3.46Safe
Confidence?59%Low
Short InterestHigh
Short % of Float?14.51%High
Short Interest?52.4M
Days to Cover?6.1
Free Float361.1M
Avg Daily Volume8.6M
Settlement Date2026-07-15
Financial Health
Current Ratio?2.41Strong
Quick Ratio?2.35Strong
Cash Ratio?0.80Adequate
Debt/Equity?0.08Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.92CHEAP▾
Peers70
S&P57
P/S?9.72HIGH▾
Peers55
S&P9
P/FCF?N/A▾
EV/EBITDA?-6.4CHEAP▾
Peers100
S&P97
EV/Sales?9.13HIGH▾
Peers55
S&P13
Returns & Efficiency
ROE?-43.1%WEAK▾
Peers11
S&P3
ROA?-27.8%WEAK▾
Peers13
S&P3
Cash Flow & Enterprise
FCF?$-1603000000
Enterprise Value?$20.3B
Fundamentals ratios updated end of day